Ranolazine maintained sinus rhythm in a patient with refractory symptomatic atrial fibrillation

Cardiovasc Ther. 2013 Oct;31(5):303-6. doi: 10.1111/1755-5922.12017.

Abstract

We report on a patient who was treated with several antiarrhythmic drugs as well as different ablation strategies. Nevertheless, symptomatic atrial fibrillation always recurred until an off-label use with ranolazine was started. We could demonstrate potent effects of ranolazine on atrial fibrillation in a "wash-in wash-out" situation. Although promising controlled studies are needed to investigate a potential role of ranolazine for the treatment of atrial fibrillation.

Keywords: Antiarrhythmic drugs; Atrial fibrillation; Pulmonary vein isolation; Ranolazine.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetanilides / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / physiopathology
  • Electrocardiography
  • Female
  • Heart Rate / drug effects*
  • Humans
  • Middle Aged
  • Piperazines / therapeutic use*
  • Ranolazine

Substances

  • Acetanilides
  • Anti-Arrhythmia Agents
  • Piperazines
  • Ranolazine